Jonathan David Schwartz - Chief Science & Gene Therapy Officer at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Science & Gene Therapy Officer
Stock Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan David Schwartz - trading volume in the past year for Rocket Pharmaceuticals, Inc.

Holdings reported by Jonathan David Schwartz for Rocket Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 120K $1.8M $15.04 Feb 11, 2025 Direct Common Stock
Common Stock 299K $892K $2.98 Nov 18, 2025 Direct

Transactions reported by Jonathan David Schwartz for Rocket Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.